Nulojix (belatacept): Risk of medication errors due to change in maintenance dose from 5 mg/kg to 6 mg/kg
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Nulojix
|
| Active substance |
belatacept
|
| Therapeutic area (MeSH) |
|
| Procedure number |
EMEA/H/C/002098/II/0079/G
|
| Regulatory outcome |
Maintenance
|
| DHPC type |
Medication error
|
| Human ATC code |
L04AA28
|
| Dissemination date |
12/09/2022
|